COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

NCI Cancer MoonshotSM Biobank Launches Exclusively through 20 NCORP Sites

Posted: October 19, 2020

NCI has launched the Cancer MoonshotSM Biobank to procure and distribute longitudinal patient biospecimens for cancer research exclusively through 20 community research sites in the NCI Community Oncology Research Program (NCORP).

Both the biobank pilot study, “NCORP Tissue Procurement Protocol: An NCI Cancer MoonshotSM Study” (P10231), and the “Cancer Moonshot Biobank” (P10323 ) are conducted within the NCORP Community and Minority/Underserved Community Sites. Twelve NCORP sites are involved in P10231 and 20 Sites are involved in P10323. A total of 81 NCORP affiliates of the 20 NCORPs sites have joined the effort.

For more information view the full article at: NCI DCTD News

 

 

 

 

 

 

 

 

˄
BACK TO
TOP